NCT05814913

Brief Summary

Primary Aims: To determine the clinical efficacy of Culturally adapted Cognitive Behavioral Therapy (CaCBT) and Culturally adapted Family Intervention (CulFI) compared to Treatment As Usual (TAU) on reducing overall symptoms of psychosis in patients with First Episode Psychosis (FEP) in Pakistan. Secondary Aims:

  1. 1.To determine the efficacy of CaCBT and CulFI compared to TAU on positive and negative symptoms of psychosis, general psychopathology, depressive symptoms, quality of life, general functioning, and insight in patients with FEP in Pakistan.
  2. 2.To determine the efficacy of CaCBT and CulFI compared to TAU on improving carer experience, carer wellbeing, carer illness attitudes and symptoms of depression and anxiety in family and carers of patients with FEP in Pakistan.
  3. 3.To determine the comparative effect of CaCBT and CulFI in improving patient and carer related outcomes in individuals with FEP in Pakistan.
  4. 4.To estimate the economic impact of delivering culturally appropriate psychosocial interventions in low-resource settings
  5. 5.To explore delivery and reach of each intervention, tolerability of intervention components, acceptability of interventions, understanding mechanism of change and developing an understanding of barriers and facilitators to future adoption using process evaluation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
390

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Apr 2024Dec 2026

First Submitted

Initial submission to the registry

April 3, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 18, 2023

Completed
12 months until next milestone

Study Start

First participant enrolled

April 15, 2024

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

December 12, 2024

Status Verified

December 1, 2024

Enrollment Period

2.2 years

First QC Date

April 3, 2023

Last Update Submit

December 7, 2024

Conditions

Keywords

First Episode PsychosisLAMICFamily InterventionCBTPaksitan

Outcome Measures

Primary Outcomes (1)

  • Positive and Negative Syndrome Scale

    The PANSS is a structured interview use to evaluate the prevalence and severity of the positive, negative and general psychiatric symptoms of schizophrenia. The higher the score the greater symptoms severity. potential ranges are 7 to 49 for the Positive and Negative Scales, and 16 to 112 for the General Psychopathology Scale.

    Change in scores from baseline to months 3, 6, and 12

Secondary Outcomes (22)

  • Calgary Depression Scale for Schizophrenia

    Change in scores from baseline to months 3, 6, and 12

  • EuroQol-5 Dimensions

    Change in scores from baseline to months 3, 6, and 12

  • World Health Organization Disability Assessment Scale

    Change in scores from baseline to months 3, 6, and 12

  • Schedule for Assessment of Insight

    Change in scores from baseline to months 3, 6, and 12

  • Experience of Caregiving Inventory

    Change in scores from baseline to months 3, 6, and 12

  • +17 more secondary outcomes

Study Arms (3)

CaCBT for psychosis

EXPERIMENTAL

CaCBT is a culturally adapted psychosocial intervention for people with early psychosis that comprises of 12 sessions. These sessions are conducted individually on a weekly basis and last 45-60 minutes

Behavioral: CaCBT for psychosis

CulFI Intervention

EXPERIMENTAL

CulFI is a culturally adapted psychosocial intervention delivered over 10 sessions of 40-60 minutes, weekly for the first 8 weeks and fortnightly for the remaining 4 weeks. Sessions are delivered to patients and their carers, though patient participation in sessions is not necessary.

Behavioral: Culturally adapted Family Intervention (CulFI) for psychosis

Treatment as Usual (TAU)

NO INTERVENTION

TAU will be ascertained by the participant's treating physician. Research staff will record the nature and intensity of TAU delivered to each participant over a period of 3 months.

Interventions

The CaCBT intervention is based on the intervention manual developed by David Kingdon and Douglas Turkington, and culturally adapted by our group. CaCBT aims to take a collaborative approach to gaining an understanding of the symptoms

CaCBT for psychosis

CulFI intervention comprises of Family psychoeducation; cognitive-behavioural skills training for stress-management, coping and problem solving; crisis intervention and suicide risk management; relapse prevention; education and support regarding the family environment, including communication training. The components are designed to facilitate an understanding about psychosis, the emotional impact of the illness on family relationships, to promote more adaptive coping strategies and minimize relapse risk.

CulFI Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals of all genders aged over 18 years; diagnosis of schizophrenia confirmed by Structured Clinical Interview for DSM (SCID) meeting DSM-5 criteria for schizophrenia, schizophreniform or schizoaffective psychosis
  • Scored at least 4 on the PANSS delusions or hallucinations items, or at least 5 on suspiciousness, persecution, or grandiosity items
  • stable on medication for the past four weeks
  • in contact with mental health services
  • within 3 years of diagnosis
  • able to demonstrate the capacity to provide informed consent to take part in the study
  • potential participants must have a carer or relative who is also willing to participate in the study to be eligible

You may not qualify if:

  • Active DSM-5 substance use disorder (except nicotine or caffeine) or dependence within the last three months
  • A score of 5 or more on the PANSS conceptual disorganisation item
  • Individuals who have received structured psychological intervention within the past 3 months
  • Relevant CNS or other medical disorders that would impact participation
  • Diagnosis of intellectual disability
  • Unstable residential arrangements
  • Living with or spending at least 10 hours per week in face-to-face contact with an individual with early psychosis and assuming a caring role
  • Age\>18 years
  • Able to give informed written consent.
  • Active DSM-5 substance use disorder
  • Received psychological intervention within the past 3 months
  • Unstable residential arrangements.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Civil hospital

Karachi, Sindh, 75600, Pakistan

RECRUITING

Related Publications (1)

  • Husain MO, Khoso AB, Kiran T, Chaudhry N, Husain MI, Asif M, Ansari M, Rajput AH, Dawood S, Naqvi HA, Nizami AT, Tareen Z, Rumi J, Sherzad S, Khan HA, Bhatia MR, Siddiqui KMS, Zadeh Z, Mehmood N, Talib U, de Oliveira C, Naeem F, Wang W, Voineskos A, Husain N, Foussias G, Chaudhry IB. Culturally adapted psychosocial interventions (CaPSI) for early psychosis in a low-resource setting: study protocol for a large multi-center RCT. BMC Psychiatry. 2023 Jun 16;23(1):444. doi: 10.1186/s12888-023-04904-8.

MeSH Terms

Conditions

Psychotic Disorders

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • Omair Husain, MD

    Centre for Addiction and Mental Health

    PRINCIPAL INVESTIGATOR
  • Imran B Chaudhry, MD

    Pakistan Institute of Living and Learning

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Researchers doing outcome assessment will be blind to treatment allocation
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2023

First Posted

April 18, 2023

Study Start

April 15, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

December 12, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations